CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kubota, Y.
Right arrow Articles by Ullrich, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kubota, Y.
Right arrow Articles by Ullrich, A.

Cell Growth & Differentiation, Vol 9, Issue 3 247-256, Copyright © 1998 by American Association of Cancer Research


ARTICLES

Activation of phosphatidylinositol 3-kinase is necessary for differentiation of FDC-P1 cells following stimulation of type III receptor tyrosine kinases

Y Kubota, T Angelotti, G Niederfellner, R Herbst and A Ullrich
Department of Molecular Biology, Max-Planck-Institut fur Biochemie, Martinsried, Germany.

Signaling molecules that are responsible for proliferation and differentiation of hematopoietic cells following ectopic expression of receptor tyrosine kinases (RTKs) were investigated in the interleukin 3 (IL-3)-dependent hematopoietic cell line, FDC-P1. Cells were transfected with human platelet-derived growth factor receptor (PDGF-R), macrophage colony stimulating factor-1 receptor (CSF-1R), epidermal growth factor receptor (EGF-R), and chimeras consisting of the extracellular domain of EGF-R and the transmembrane and cytoplasmic domains of either HER2 (HER1-2) or c-kit (EK-R). All FDC-P1 transfectants proliferated in response to the corresponding growth factor in the absence of IL-3. However, only cells expressing PDGF-R, CSF-1R, and EK-R (type III RTKs) differentiated along the monocyte-macrophage lineage after treatment with their activating ligands. Analysis of proteins from these RTK-expressing cells revealed that a Mr 85,000 protein showed in vitro phosphorylation, and V8 protease peptide mapping showed that this protein was p85, the regulatory subunit of phosphatidylinositol 3-kinase (PI3-kinase). Accordingly, activation of PDGF-R-, CSF-1R-, and EK-R-expressing cells led to an increase in PI3-kinase activity. Expression of EK-R mutant Y721F, which lacked the known p85 binding site, blocked differentiation and activation of PI3-kinase, without affecting proliferation. Last, addition of wortmannin to cells expressing PDGF-R, CSF-1R, and EK-R blocked ligand-induced differentiation in a concentration-dependent manner, and this effect correlated with wortmannin's ability to inhibit PI3-kinase. Thus, ectopic expression of both type I and III RTKs could stimulate FDC-P1 proliferation in the absence of IL-3; however, only activation of type III RTKs led to differentiation via selective coupling to p85 and PI3-kinase activation.


This article has been cited by other articles:


Home page
J Biol ChemHome page
S. Blencke, A. Ullrich, and H. Daub
Mutation of Threonine 766 in the Epidermal Growth Factor Receptor Reveals a Hotspot for Resistance Formation against Selective Tyrosine Kinase Inhibitors
J. Biol. Chem., April 25, 2003; 278(17): 15435 - 15440.
[Abstract] [Full Text] [PDF]


Home page
EMBO J.Home page
Y. Kubota, T. Tanaka, A. Kitanaka, H. Ohnishi, Y. Okutani, M. Waki, T. Ishida, and H. Kamano
Src transduces erythropoietin-induced differentiation signals through phosphatidylinositol 3-kinase
EMBO J., October 15, 2001; 20(20): 5666 - 5677.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Chian, S. Young, A. Danilkovitch-Miagkova, L. Ronnstrand, E. Leonard, P. Ferrao, L. Ashman, and D. Linnekin
Phosphatidylinositol 3 kinase contributes to the transformation of hematopoietic cells by the D816V c-Kit mutant
Blood, September 1, 2001; 98(5): 1365 - 1373.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. B. van Dijk, E. van den Akker, M. P.-v. Amelsvoort, H. Mano, B. Lowenberg, and M. von Lindern
Stem cell factor induces phosphatidylinositol 3'-kinase-dependent Lyn/Tec/Dok-1 complex formation in hematopoietic cells
Blood, November 15, 2000; 96(10): 3406 - 3413.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Zhang and B. M. Steinberg
Overexpression of PTEN/MMAC1 and Decreased Activation of Akt in Human Papillomavirus-infected Laryngeal Papillomas
Cancer Res., March 1, 2000; 60(5): 1457 - 1462.
[Abstract] [Full Text]


Home page
JEMHome page
Z. Hmama, D. Nandan, L. Sly, K. L. Knutson, P. Herrera-Velit, and N. E. Reiner
1{alpha},25-Dihydroxyvitamin D3-Induced Myeloid Cell Differentiation Is Regulated by a Vitamin D Receptor-Phosphatidylinositol 3-Kinase Signaling Complex
J. Exp. Med., December 6, 1999; 190(11): 1583 - 1594.
[Abstract] [Full Text] [PDF]


Home page
EMBO J.Home page
P. D. Sepulveda, K. Okkenhaug, J. L. Rose, R. G. Hawley, P. Dubreuil, and R. Rottapel
Socs1 binds to multiple signalling proteins and suppresses Steel factor-dependent proliferation
EMBO J., February 15, 1999; 18(4): 904 - 915.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1998 by the American Association of Cancer Research.